The conference will take place in Shanghai on June 23, one day before the beginning of Fi Asia-China.
In hopes of expanding the market for probiotic and omega-3 dietary supplements inside China’s strict regulatory environment, the U.S.-China Health Products Association (USCHPA; Lewes, DE) is organizing the China International Probiotic and Omega-3 Industry Summit to take place in Shanghai on June 23.
The goal of the event is “to promote and share valuable industry information as well as bring the industry together,” according to a release from USCHPA, a non-profit association dedicated to promoting commerce between the United States and China. The summit will take place the day before the beginning of the Fi Asia-China event that takes place on June 24-26, also in Shanghai.
According to USCHPA, probiotics and omega-3s are “two leading segments of the global dietary supplement industry,” but the ingredients have failed to reach their full potential in China due to the strict regulatory environment that has “curtailed investment in R&D and market entry endeavors.”
Topics to be covered at the event include:
· Global market trends of probiotics and omega-3s
· China registration and approval processes
· Insights to China’s new food safety law and its impact on dietary supplements
· Introduction to China’s growing cross border and B2C e-commerce platforms
· Health benefits and current research of both probiotics and omega-3s
USCHPA will also be joined by several global industry partners in creating the event, including the China Clinical Nutritional Alliance, China Gate Consulting, Euromonitor International, the Global Organization for EPA and DHA Omega-3s, and the International Probiotic Association.
The one-day event will take place at the Marriott Renaissance Yu Garden Hotel in Shanghai, followed by a two-hour cocktail networking party on the 21st floor of the hotel.
To learn more about attending the event, visit www.uchinahpa.org or send and email to info@uschinahpa.org.
Read more:
China’s New Dietary Supplement Law Goes into Effect in October. But Will It Solve the Problems?
China Should Be the Largest Market for Dietary Supplements. So Why Have Exports to China Stopped?
Nutritional Outlook's Best of 2014: U.S.–China Health Products Association
Michael Crane
Associate Editor
Nutritional Outlook magazine
michaeel.crane@ubm.com
Photo © iStockphoto.com/jpa1999
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.